K161E (p.Lys161Glu) variant of APP (Amyloid-beta precursor protein)
K161E (p.Lys161Glu) in APP (Amyloid-beta precursor protein) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
K161E (p.Lys161Glu) variant details
- p.Lys161Glu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available